Kalos Management’s Boston Scientific BSX Stock Holding History

Kalos Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-43,327	Closed	-$1.96M	–	208
2019 Q4	$1.96M	Sell	43,327 -503	-1%	-$21K	0.71%	48
2019 Q3	$1.78M	Buy	43,830 +12,707	+41%	+$538K	0.71%	43
2019 Q2	$1.1M	Buy	31,123 +5,639	+22%	+$217K	0.5%	56
2019 Q1	$978K	Sell	25,484 -5,639	-18%	-$215K	0.63%	47
2018 Q4	$1.1M	Buy	31,123 +315	+1%	+$11.4K	0.54%	55
2018 Q3	$1.19M	Buy	30,808 +1,526	+5%	+$53.3K	0.64%	43
2018 Q2	$957K	Buy	+29,282	New	+$883K	0.43%	63

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Kalos Management's BSX Position: Q1 2020 in Review

Kalos Management sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 43,327 shares — an estimated $1.96M sold.

Kalos Management first reported a position in BSX in Q2 2018 and held it in 7 quarters. The position peaked at $1.96M in Q4 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

Kalos Management reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
Kalos Management sold 43,327 Boston Scientific shares in Q1 2020, an estimated $1.96M.
Kalos Management first reported a position in Boston Scientific in Q2 2018 and held it in 7 quarters.
Kalos Management's Boston Scientific position peaked at $1.96M in Q4 2019.
800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Kalos Management's 13F filing for Q1 2020, filed 13 May 2020.